Increased circulating levels of PTX3 were observed in myeloproliferative neoplasms (124), soft tissue sarcomas (125), lung cancers (126–128), pancreatic carcinomas (129), gliomas (130), and hepatocellular carcinomas (131). Here, PTX3 is linked to lung carcinoma.